Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Dec 7, 2015 at 11:45 AM EST

Idera Pharma Soars Over Positive Trial Data

Idera Pharmaceuticals made a strong push in Monday’s session following the presentation of its clinical data over the weekend.

Chris Lange | Dec 7, 2015 at 11:10 AM EST

MEI Pharma Bounces Off Lows After Positive Phase 2 Results

MEI Pharma Inc. (NASDAQ: MEIP) was leading the bulls in the broad markets Monday on news of positive Phase 2…

Chris Lange | Dec 5, 2015 at 10:15 AM EST

Top 6 BioPharma Movers of the Week

These biotech companies stood out from the rest with incredible gains or losses over the course of the past week.

Chris Lange | Dec 4, 2015 at 11:50 AM EST

KaloBios Continues to Rally on Private Placement

KaloBios Pharmaceuticals continues to vastly outperform the broad markets through December after Martin Shkreli took the helm.

Chris Lange | Dec 3, 2015 at 12:10 PM EST

Foamix Soars on Positive Phase 2 Results

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) was leading the bulls early in Thursday’s session on positive results from a Phase 2…

Chris Lange | Dec 3, 2015 at 11:45 AM EST

Rite Aid Announces November Sales

Rite Aid reported its sales results for its retail pharmacy segment for the month of November before the markets opened…

Chris Lange | Dec 3, 2015 at 9:15 AM EST

Medtronic Earnings Solid as Covidien Integration Continues

Medtronic reported better-than-expected fiscal second-quarter financial results before the markets opened on Thursday.

Chris Lange | Dec 2, 2015 at 1:40 PM EST

What to Expect From Medtronic Earnings

Medtronic is scheduled to report its fiscal second-quarter financial results after the markets close on Thursday.

Lee Jackson | Dec 2, 2015 at 10:20 AM EST

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

A new Jefferies research report focuses on some biotech and specialty pharmaceutical stocks that have had some headline and clinical…

Chris Lange | Dec 2, 2015 at 9:45 AM EST

InVivo Continues to Rally With New SCI Treatment Strategy

InVivo Therapeutics announced a new strategy for the treatment of chronic spinal cord injury.

Chris Lange | Dec 2, 2015 at 9:05 AM EST

Is This a Buying Opportunity for Zafgen?

It looks like Wednesday will be a huge day for Zafgen, considering the most recent development in the beloranib study.

Chris Lange | Dec 1, 2015 at 11:15 AM EST

Aeterna Zentaris Rises on Finalized Marketing Agreement

Aeterna Zentaris announced that it has finalized of a co-marketing agreement with Armune BioScience that will allow it to promote…

Lee Jackson | Dec 1, 2015 at 8:25 AM EST

Huge PowerShares ETF Rebalance Means Massive Buying for 4 Biotech Stocks

On the close Tuesday, the PowerShares Dynamic exchange traded funds (ETFs) are set for a rebalance. These four stocks that…

Chris Lange | Nov 30, 2015 at 1:35 PM EST

Arena Pharma Soars on FDA Approval

Arena Pharmaceuticals saw its shares jump in Monday’s session on news of an U.S. Food and Drug Administration (FDA) approval.

Chris Lange | Nov 30, 2015 at 1:10 PM EST

Anavex Takes Off on Positive Alzheimer’s Data

Anavex Life Sciences announced the publication of further data for Anavex 3-71 in the peer-reviewed scientific journal Neurodegenerative Diseases.

1 … 232 233 234 235 236 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Idera Pharma Soars Over Positive Trial Data

MEI Pharma Bounces Off Lows After Positive Phase 2 Results

Top 6 BioPharma Movers of the Week

KaloBios Continues to Rally on Private Placement

Foamix Soars on Positive Phase 2 Results

Rite Aid Announces November Sales

Medtronic Earnings Solid as Covidien Integration Continues

What to Expect From Medtronic Earnings

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

InVivo Continues to Rally With New SCI Treatment Strategy

Is This a Buying Opportunity for Zafgen?

Aeterna Zentaris Rises on Finalized Marketing Agreement

Huge PowerShares ETF Rebalance Means Massive Buying for 4 Biotech Stocks

Arena Pharma Soars on FDA Approval

Anavex Takes Off on Positive Alzheimer’s Data

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Circle, Coinbase, Strategy Rise Again on Tuesday: How a Stablecoin Rule Tweak Reignited the Crypto Trade

$1,000 Invested in This 2016 IPO Would Be Worth $4,700 Today, Crushing the S&P 500

Oxford Square’s 21% Yield Masks a Crumbling Portfolio

Is College Still Worth It? Ron Lieber's Advice for Parents Navigating Shifting Job Market

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

Circle, Coinbase, Strategy Rise Again on Tuesday: How a Stablecoin Rule Tweak Reignited the Crypto Trade

$1,000 Invested in This 2016 IPO Would Be Worth $4,700 Today, Crushing the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

Idera Pharma Soars Over Positive Trial Data

MEI Pharma Bounces Off Lows After Positive Phase 2 Results

Top 6 BioPharma Movers of the Week

KaloBios Continues to Rally on Private Placement

Foamix Soars on Positive Phase 2 Results

Rite Aid Announces November Sales

Medtronic Earnings Solid as Covidien Integration Continues

What to Expect From Medtronic Earnings

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

InVivo Continues to Rally With New SCI Treatment Strategy

Is This a Buying Opportunity for Zafgen?

Aeterna Zentaris Rises on Finalized Marketing Agreement

Huge PowerShares ETF Rebalance Means Massive Buying for 4 Biotech Stocks

Arena Pharma Soars on FDA Approval

Anavex Takes Off on Positive Alzheimer’s Data

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Circle, Coinbase, Strategy Rise Again on Tuesday: How a Stablecoin Rule Tweak Reignited the Crypto Trade

$1,000 Invested in This 2016 IPO Would Be Worth $4,700 Today, Crushing the S&P 500

Oxford Square’s 21% Yield Masks a Crumbling Portfolio

Featured Reads

Is College Still Worth It? Ron Lieber's Advice for Parents Navigating Shifting Job Market

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife